Environmental risk factors and Amyotrophic Lateral Sclerosis (ALS): A case-control study of ALS in Michigan

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Yu, Yu ^a   Su, Feng Chiao ^a   Callaghan, Brian C ^b   Goutman, Stephen A ^b   Batterman, Stuart A ^a   Feldman, Eva L ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERTILIZER; METAL; PESTICIDE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DUST; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; FIBER; FUME; GAS; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PHYSICAL ACTIVITY; RISK FACTOR; SMOKING; TIME SERIES ANALYSIS; UNITED STATES; ADVERSE EFFECTS; AGED; ENVIRONMENT; MIDDLE AGED; MOTOR ACTIVITY; REGRESSION ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; DEMOGRAPHY; ENVIRONMENT; FEMALE; HUMANS; MALE; MICHIGAN; MIDDLE AGED; MOTOR ACTIVITY; REGRESSION ANALYSIS; RISK FACTORS; SMOKING;

EID: 84903650117     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101186     Document Type: Article

References (65)

1. Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 124 Suppl: 96-107.
2. Bobowick AR, Brody JA (1973) Epidemiology of motor-neuron diseases. N Engl J Med 288: 1047-1055.
3. Annegers JF, Appel S, Lee JR, Perkins P (1991) Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Arch Neurol 48: 589-593.
4. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, et al. (1999) Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 52: 504-509.
5. Ahmed A, Wicklund MP (2011) Amyotrophic lateral sclerosis: what role does environment play? Neurologic Clinics 29: 689-711.
6. Chancellor A, Warlow C (1992) Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. Journal of Neurology, Neurosurgery & Psychiatry 55: 1106-1115.
7. McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G (1996) Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 47: 571-573.
8. NINDS (2012) Amyotrophic Lateral Sclerosis (ALS) Fact Sheet. National Institute of Neurological Disorders and Stroke, National Institutes of Health.
9. Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, et al. (2002) Lead exposure and amyotrophic lateral sclerosis. Epidemiology 13: 311-319.
10. Armon C, Kurland LT, Daube JR, O'Brien PC (1991) Epidemiologic correlates of sporadic amyotrophic lateral sclerosis. Neurology 41: 1077-1084.
11. McGuire V, Longstreth WT, Nelson LM, Koepsell TD, Checkoway H, et al. (1997) Occupational exposures and amyotrophic lateral sclerosis. A populationbased case-control study. American Journal of Epidemiology 145: 1076-1088.
12. Nelson L (1995) Epidemiology of ALS. Clinical Neuroscience 3: 327-331.
13. Sutedja N, Veldink JH, Fischer K, Kromhout H, Heederik D, et al. (2009) Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review. Amyotrophic Lateral Sclerosis 10: 302-309.
14. Qureshi MM, Hayden D, Urbinelli L, Ferrante K, Newhall K, et al. (2006) Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis 7: 173-182.
15. Fang F, Quinlan P, Ye W, Barber MK, Umbach DM, et al. (2009) Workplace exposures and the risk of amyotrophic lateral sclerosis. Environ Health Perspect 117: 1387-1392.
16. Fang F, Kwee LC, Allen KD, Umbach DM, Ye W, et al. (2010) Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol 171: 1126-1133.
17. Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 1: 293-299.
18. CDC NCHS (2013) National Health and Nutrition Examination Survey Questionnaire. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention.
19. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, et al. (2009) Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics 42: 377-381.
20. Malek AM, Barchowsky A, Bowser R, Heiman-Patterson T, Lacomis D, et al. (2013) Environmental and Occupational Risk Factors for Amyotrophic Lateral Sclerosis: A Case-Control Study. Neurodegenerative Diseases.
21. Chiba M, Masironi R (1992) Toxic and trace elements in tobacco and tobacco smoke. Bull World Health Organ 70: 269-275.
22. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, et al. (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332: 1198-1203.
23. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF (2007) Systemic effects of smoking. Chest 131: 1557-1566.
24. Weisskopf MG, Ascherio A (2009) Cigarettes and amyotrophic lateral sclerosis: only smoke or also fire? Ann Neurol 65: 361-362.
25. Weisskopf MG, Morozova N, O'Reilly EJ, McCullough ML, Calle EE, et al. (2009) Prospective study of chemical exposures and amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 80: 558-561.
26. Nelson LM, McGuire V, Longstreth WT Jr, Matkin C (2000) Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol 151: 156-163.
27. Alonso A, Logroscino G, Jick SS, Hernan MA (2010) Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study. BMC Neurol 10: 6.
28. Weisskopf MG, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, et al. (2004) Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol 160: 26-33.
29. Savettieri G, Salemi G, Arcara A, Cassata M, Castiglione MG, et al. (1991) A Case-Control Study of Amyotrophic Lateral Sclerosis. Neuroepidemiology 10: 242-245.
30. Armon C (2009) Smoking may be considered an established risk factor for sporadic ALS. Neurology 73: 1693-1698.
31. Longstreth W, Nelson L, Koepsell T, Van Belle G (1991) Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis. Medical hypotheses 34: 144-148.
32. Longstreth WT, McGuire V, Koepsell TD, Wang Y, van Belle G (1998) Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Arch Neurol 55: 201-206.
33. Riggs JE (2001) The latency between traumatic axonal injury and the onset of amyotrophic lateral sclerosis in young adult men. Military medicine 166: 731-732.
34. Muddasir Qureshi M, Hayden D, Urbinelli L, Ferrante K, Newhall K, et al. (2006) Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis 7: 173-182.
35. Morahan JM, Pamphlett R (2006) Amyotrophic Lateral Sclerosis and Exposure to Environmental Toxins: An Australian Case-Control Study. Neuroepidemiology 27: 130-135.
36. Horner RD, Grambow SC, Coffman CJ, Lindquist JH, Oddone EZ, et al. (2008) Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak. Neuroepidemiology 31: 28-32.
37. Kasarskis EJ, Lindquist JH, Coffman CJ, Grambow SC, Feussner JR, et al. (2009) Clinical aspects of ALS in Gulf War veterans. Amyotroph Lateral Scler 10: 35-41.
38. Elbaz A, Dufouil C, Alperovitch A (2007) Interaction between genes and environment in neurodegenerative diseases. C R Biol 330: 318-328.
39. Stozicka Z, Zilka N, Novak M (2007) Risk and protective factors for sporadic Alzheimer's disease. Acta Virol 51: 205-222.
40. Park RM, Schulte PA, Bowman JD, Walker JT, Bondy SC, et al. (2005) Potential occupational risks for neurodegenerative diseases. American Journal of Industrial Medicine 48: 63-77.
41. Bharucha NE, Schoenberg BS, Raven RH, Pickle LW, Byar DP, et al. (1983) Geographic distribution of motor neuron disease and correlation with possible etiologic factors. Neurology 33: 911-915.
42. Kalfakis N, Vassilopoulos D, Voumvourakis C, Ndjeveleka M, Papageorgiou C (1991) Amyotrophic lateral sclerosis in southern Greece: an epidemiologic study. Neuroepidemiology 10: 170-173.
43. Giagheddu M, Puggioni G, Masala C, Biancu F, Pirari G, et al. (1983) Epidemiologic study of amyotrophic lateral sclerosis in Sardinia, Italy. Acta Neurol Scand 68: 394-404.
44. Callaghan B, Feldman D, Gruis K, Feldman E (2011) The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications. Neurodegenerative Diseases 8: 1-8.
45. Kapaki E, Segditsa J, Zournas C, Xenos D, Papageorgiou C (1989) Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases. Experientia 45: 1108-1110.
46. Stober T, Stelte W, Kunze K (1983) Lead concentrations in blood, plasma, erythrocytes, and cerebrospinal fluid in amyotrophic lateral sclerosis. J Neurol Sci 61: 21-26.
47. Bergomi M, Vinceti M, Nacci G, Pietrini V, Bratter P, et al. (2002) Environmental exposure to trace elements and risk of amyotrophic lateral sclerosis: a population-based case-control study. Environ Res 89: 116-123.
48. Fang F, Quinlan P, Ye W, Barber M, Umbach D, et al. (2009) Workplace Exposures and the Risk of Amyotrophic Lateral Sclerosis. Environmental Health Perspectives 117: 1387-1392.
49. Moriwaka F, Satoh H, Ejima A, Watanabe C, Tashiro K, et al. (1993) Mercury and selenium contents in amyotrophic lateral sclerosis in Hokkaido, the northernmost island of Japan. Journal of the Neurological Sciences 118: 38-42.
50. Vinceti M, Guidetti D, Bergomi M, Caselgrandi E, Vivoli R, et al. (1997) Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis. Italian Journal of Neurological Sciences 18: 87-92.
51. Moriwaka F, Satoh H, Ejima A, Watanabe C, Tashiro K, et al. (1993) Mercury and selenium contents in amyotrophic lateral sclerosis in Hokkaido, the northernmost island of Japan. J Neurol Sci 118: 38-42.
52. Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI (1996) Amyotrophic lateral sclerosis and occupational history: A pilot case-control study. Archives of Neurology 53: 730-733.
53. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, et al. (2002) Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 65: 1513-1530.
54. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, et al. (2002) Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 65: 1531-1543.
55. Lockman PR, Koziara JM, Mumper RJ, Allen DD (2004) Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 12: 635-641.
56. Farrell DF, Starr A (1968) Delayed neurological sequelae of electrical injuries. Neurology 18: 601-606.
57. Noonan CW, Reif JS, Yost M, Touchstone J (2002) Occupational exposure to magnetic fields in case-referent studies of neurodegenerative diseases. Scand J Work Environ Health 28: 42-48.
58. Davanipour Z, Sobel E, Bowman JD, Qian Z, Will AD (1997) Amyotrophic lateral sclerosis and occupational exposure to electromagnetic fields. Bioelectromagnetics 18: 28-35.
59. Savitz DA, Loomis DP, Tse CK (1998) Electrical occupations and neurodegenerative disease: analysis of U.S. mortality data. Arch Environ Health 53: 71-74.
60. Savitz DA, Checkoway H, Loomis DP (1998) Magnetic field exposure and neurodegenerative disease mortality among electric utility workers. Epidemiology 9: 398-404.
61. Johansen C (2000) Exposure to electromagnetic fields and risk of central nervous system disease in utility workers. Epidemiology 11: 539-543.
62. Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, et al. (2009) Smoking and risk for amyotrophic lateral sclerosis: Analysis of the EPIC cohort. Annals of Neurology 65: 378-385.
63. Brown RC, Lockwood AH, Sonawane BR (2005) Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 113: 1250-1256.
64. Sutedja N, Veldink JH, Fischer K, Kromhout H, Wokke JHJ, et al. (2007) Lifetime occupation, education, smoking, and risk of ALS. Neurology 69: 1508-1514.
65. Weisskopf MG, McCullough ML, Morozova N, Calle EE, Thun MJ, et al. (2005) Prospective Study of Occupation and Amyotrophic Lateral Sclerosis Mortality. American Journal of Epidemiology 162: 1146-1152.